Our Publications

Our publications over the years

Full list of publication

Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies

Reho, P., Saez-Atienzar, S., Ruffo, P., Solaiman, S., Shah, Z., Chia, R., Kaivola, K., Traynor, B.J., Tilley, B.S., Gentleman, S.M., Hodges, A.K., Aarsland, D., Monuki, E.S., Newell, K.L., Woltjer, R., Albert, M.S., Dawson, T.M., Rosenthal, L.S., Troncoso, J.C., Pletnikova, O., Serrano, G.E., Beach, T.G., Easwaran, H.P., Scholz, S.W.(2024). Commun Biol., 7(1):35. doi: 10.1038/s42003-023-05725-x.

Association of cardiovascular disease management drugs with Lewy body dementia: a case-control study

Scholz, S.W., Moroz B.E., Saez-Atienzar, S., Chia, R., Cahoon, E.K., Dalgard C.L., The American Genome Center, International Lewy Body Dementia Genomics Consortium, Freedman M.D., Pfeiffer R.M. (2023). Brain Communications, fcad346

Reply to Zhu et al.: Implications of CHRNB1and ERBB2in the pathobiology of myasthenia gravis.

Chia, R., Saez-Atienzar, S., Drachman, D.B., Traynor, B.J. (2022). Proceedings of the National Academy of Sciences of the United States of America, 119 (36) e2209096119

ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function

Baron, D.M*., Fenton, A.R*., Saez-Atienzar, S*., Giampetruzzi, A., Sreeram, A. Shankaracharya., Keagle, P. J., Doocy, V.R., Smith, N.J., Danielson, E.W., Andresano, M., McCormack, M.C., Garcia, J., Bercier, V., Van Den Bosch, L., Brent, J.R., Fallini, C., Traynor, B.J., Holzbaur, E.L.F., Landers, J.E. (2022). Cell Rep., 5;39(1):110598 (* equal contribution)

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Chia, R., Saez-Atienzar, S., Murphy, N., Chiò, A., Blauwendraat, C., International Myasthenia Gravis Genomics Consortium, Roda, R. H., Tienari, P. J., Kaminski, H. J., Ricciardi, R., Guida, M., De Rosa, A., Petrucci, L., Evoli, A., Provenzano, C., Drachman, D. B., & Traynor, B. J. (2022). Proceedings of the National Academy of Sciences of the United States of America, 119(5)

Combined epigenetic/genetic study identified an ALS age of onset modifier

Zhang, M., Xi, Z., Saez-Atienzar, S., Chia, R., Moreno, D., Sato, C., Montazer Haghighi, M., Traynor, B. J., Zinman, L., & Rogaeva, E. (2021). Acta Neuropathologica Communications, 9(1), 75

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Chia, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., Makarious, M. B., Diez-Fairen, M., ...Scholz, S. W. (2021). Nature Genetics, 53(3), 294–303

Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types

Saez-Atienzar, S.*, Bandres-Ciga, S.*, Langston, R. G., Kim, J. J., Choi, S. W., Reynolds, R. H., International ALS Genomics Consortium, ITALSGEN, Abramzon, Y., Dewan, R., Ahmed, S., Landers, J. E., Chia, R., Ryten, M., Cookson, M. R., Nalls, M. A., Chiò, A., & Traynor, B. J. (2021). Science Advances, 7(3) (* equal contribution)

Identification of a pathogenic intronic KIF5A mutation in an ALS-FTD kindred. Neurology, 95(22), 1015–1018 Saez-Atienzar, S., & Masliah, E. (2020). Cellular senescence and Alzheimer’s disease: the egg and the chicken scenario

Saez-Atienzar, S., Dalgard, C. L., Ding, J., Chiò, A., Alba, C., Hupalo, D. N., Wilkerson, M. D., Bowser, R., Pioro, E. P., Bedlack, R., & Traynor, B. J. (2020). Nature Reviews Neuroscience, 21(8), 433–444

Large-scale pathway-specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson’s disease

Bandres-Ciga, S.*, Saez-Atienzar, S.*, Kim, J. J., Makarious, M. B., Faghri, F., Diez-Fairen, M., Iwaki, H., Leonard, H., Botia, J., Ryten, M., Hernandez, D., Gibbs, J. R., Ding, J., Gan-Or, Z., Noyce, A., Pihlstrom, L., …, International Parkinson Disease Genomics Consortium. (2020). Acta Neuropathologica, 140(3), 341–358 (* equal contribution)

The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson’s disease

Bandres-Ciga, S.*, Saez-Atienzar, S.*, Bonet-Ponce, L.*, Billingsley, K., Vitale, D., Blauwendraat, C., Gibbs, J. R., Pihlstrøm, L., Gan-Or, Z., International Parkinson’s Disease Genomics Consortium (IPDGC), Cookson, M. R., Nalls, M. A., & Singleton, A. B. (2019). Movement Disorders: Official Journal of the Movement Disorder Society, 34(4), 460–468 (* equal contribution)

Genetic risk factors in Parkinson’s disease. Cell and Tissue Research

Billingsley, K. J.*, Bandres-Ciga, S.*, Saez-Atienzar, S.*, & Singleton, A. B. (2018). Cell and Tissue Research, 373(1), 9–20 (* equal contribution)